Skip to main content
. 2020 Dec 15;71(705):e280–e286. doi: 10.3399/bjgp20X713993

Table 2.

Characteristics of patients diagnosed with lung cancer within 1 year and 2 years of SR-CXR

Characteristic Diagnosis in 1 year following SR-CXR Diagnosis in 2 years following SR-CXR
Patients, n (%) 114 (1.3) 154 (1.7)

Mean age, years 69 70

Male, n (%) 45 (39.5) 64 (41.6)

Smoker/ex-smoker, n (%) 107 (93.9) 145 (94.2)

SR-CXR result, n (%)
  Positive 86 (75.4) 97 (63.0)
  Negative 28 (24.6) 57 (37.0)

Stage at diagnosis, n (%)
  Stage I–II 34 (29.8) 50 (32.5)
  Stage III–IV 80 (70.2) 104 (67.5)

Tumour histology, n (%)
  Adenocarcinoma 38 (33.3) 50 (32.5)
  Squamous cell carcinoma 31 (27.2) 41 (26.6)
  Small cell carcinoma 15 (13.2) 22 (14.3)
  Non-small cell carcinoma not otherwise stated and large cella 17 (14.9) 18 (11.7)
  Unknown 13 (11.4) 23 (14.9)
a

Non-small cell group carcinoma not otherwise stated and large cell group data have been combined due to data suppression requirements that prevent reporting of identifiable groups of <5. SR-CXR = self-requested chest X-ray.